Please login to the form below

Not currently logged in
Email:
Password:

biosimilars

This page shows the latest biosimilars news and features for those working in and with pharma, biotech and healthcare.

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

The ruling could delay the arrival of biosimilar competition for Enbrel in the US by a decade. ... If Enbrel remains free from biosimilar competition until 2029, the drug will have enjoyed more than 30 years of intellectual property protection.

Latest news

More from news
Approximately 134 fully matching, plus 306 partially matching documents found.

Latest Intelligence

  • Transitions in healthcare Transitions in healthcare

    Switching from an originator biologic to a cheaper biosimilar. These are all examples of the kind of treatment transitions patients experience that can be supported by Patient Support Programmes.

  • It’s not the end of the world, is it? It’s not the end of the world, is it?

    Whether we market branded products that offer no real superiority over generics, biosimilars or me-toos or we sell innovative products whose price differential is not financially justified, much of what

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    It will compete with numerous treatment modalities, including entrenched biological agents and biosimilar biologicals.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    The world’s biggest selling drug, Humira, lost its market exclusivity in Europe to biosimilar competition in 2018, and AbbVie is well aware of the impending US patent expiry in 2022. ... Finally, 2019 will see a rapid increase in the uptake of Humira

  • Deal Watch October 2018

    None of the other biosimilars in the agreement between the two companies, in the fields of oncology and immunology, are affected. ... Sandoz’s US business has retained its biosimilars, value‐added medicines and complex generics, including the

More from intelligence
Approximately 11 fully matching, plus 56 partially matching documents found.

Latest appointments

  • Ashfield, Health Unlimited and Ashley Communications add to their teams Ashfield, Health Unlimited and Ashley Communications add to their teams

    Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar defence strategies, leading Novo’s UK diabetes team.

  • Lilly bolsters its oncology team Lilly bolsters its oncology team

    Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop

  • PharmaLex appoints Zabin Younes as associate director PharmaLex appoints Zabin Younes as associate director

    She joins the group as an associate director and arrives from ERA Consulting - a biopharmaceutical consultancy based in the UK - where she picked up experience in the biosimilar development lifecycle. ... With experience spanning over 15 years, Younes’

  • GW Pharmaceuticals strengthens research and development team GW Pharmaceuticals strengthens research and development team

    Knappertz has previously held several leadership positions including vice president of clinical development for multiple sclerosis, oncology and biosimilar products at Teva, and numerous clinical and medical roles at Bayer and

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    Novartis’ generics and biosimilar division Sandoz has appointed Tim de Gavre as its new country head for the UK. ... Our combined portfolio of small molecule generics and biosimilars makes a significant different to medicines costs, and helps the NHS

More from appointments
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 13 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics